K092322 is an FDA 510(k) clearance for the ELECSYS RUBELLA IGM IMMUNOASSAY. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Rubella (Class II - Special Controls, product code LFX).
Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on March 12, 2010, 220 days after receiving the submission on August 4, 2009.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3510.
| 510(k) Number | K092322 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | August 04, 2009 |
| Decision Date | March 12, 2010 |
| Days to Decision | 220 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LFX — Enzyme Linked Immunoabsorbent Assay, Rubella |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.3510 |